July 2018 – Page 2 – Policy & Medicine

FDA Releases Draft Guidance on Indications and Usage Labeling Sections

2019 CMS Proposed Physician Fee Schedule Includes Serious Cuts to Medicare Part B Drug Reimbursement

Lawsuit Filed Over New York Opioid Tax and Stewardship Law

FDA Releases Final Guidance on Medical Product Communications and Labeling

Consultant Found Guilty Using CMS Data for Insider Trading

Subcommittee on Health to Hold Hearing on Reforming the 340B Drug Pricing Program

CMS Releases FY 2019 IPPS and PTCH PPS Proposed Rule

FDA Publishes Draft Guidance on Expanding 510(k) Pathway

Azar Continues to Promote Administration Drug Pricing Policy, Plus RFI Published on Stark Law

Open Payments Data 2017: Significant Drop in Number of Payments